Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02218216 · ClinicalTrials.gov registry record · NA
TBI MR Study 3 Houston Methodist
A NA study, sponsored by GE Healthcare.
- Terminated
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02218216 is a NA study that was terminated before completion, run by GE Healthcare. The registered enrollment target is 16 participants.
The verdict
NCT02218216, a NA study, was terminated before completion, sponsored by GE Healthcare.
- TERMINATED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This hypothesis-generating feasibility study to determine potential associations between a broad range of clinical neurological symptoms and Magnetic Resonance Image (MRI), data, and clinical findings involved in mild traumatic brain injury (mTBI). These associations will be examined over the acute and sub-acute period (baseline to 3 months) following injury to provide information useful for optimization of MR pulse sequences for mTBI applications. The intent of this study is to broadly generate a range of potential mTBI biomarkers detectable using investigational MR pulse sequence technologies. Feasibility data attained in this study may be used for engineering program decision-making and in support of future scientific assessment, engineering development, published research databases or registries mTBI data and images, and other purposes determined by the Sponsor. The results of this study are not intended for use in regulatory submissions. Subjects will be examined on commercially available MR scanner using investigational or standard of care MR coils and a series of investigational Application Packs containing a predetermined set of MR pulse sequences optimized by Sponsor
Interventions
- DEVICE MRI Diagnostic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02218216
The ClinicalTrials.gov registry entry for NCT02218216 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI Diagnostic is the first listed.
NCT02218216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02218216 about?
NCT02218216 is a clinical study titled "TBI MR Study 3 Houston Methodist". This hypothesis-generating feasibility study to determine potential associations between a broad range of clinical neurological symptoms and Magnetic Resonance Image (MRI), data, and clinical findings involved in mild traumatic brain injury (mTBI). These associations will be examined over the acute ...
What is the current status of trial NCT02218216?
This trial is currently terminated. It is a NA study. The enrollment target is 16 participants. The study started on 2014-09. Estimated completion is 2015-11.
What interventions are being tested in trial NCT02218216?
The interventions under investigation include: MRI Diagnostic (DEVICE).
Who is sponsoring clinical trial NCT02218216?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.